Abir Alamro
Impact in
-
- Tryptophan and brain disorders
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
Papers in
- Co-authors
- Moudhi Almutlaq (7 shared papers)Samina Hyder Haq (8 shared papers)Amani Alghamdi (15 shared papers)Tlili Barhoumi (5 shared papers)Qura Tul Ain (3 shared papers)Sarah Al-Rashed (2 shared papers)Tanveer A. Wani (1 shared paper)Seema Zargar (1 shared paper)
- Journals
- Journal of King Saud University - Science (3 papers)Scientific Reports (2 papers)Heliyon (2 papers)Journal of Pharmacy and Pharmacology (1 paper)Saudi Pharmaceutical Journal (1 paper)
- Partner nations
- Saudi ArabiaPakistanUnited States
In The Last Decade
Abir Alamro
30 papers receiving 460 citations
Peers
Comparison fields: 5 of 95
- Biological Psychiatry 28
- Pharmaceutical Science 45
- Aquatic Science 51
- Molecular Medicine 32
- Pharmacology 42
Countries citing papers authored by Abir Alamro
This map shows the geographic impact of Abir Alamro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abir Alamro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abir Alamro more than expected).
Fields of papers citing papers by Abir Alamro
This network shows the impact of papers produced by Abir Alamro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abir Alamro. The network helps show where Abir Alamro may publish in the future.
Co-authors
The 25 scholars most cited alongside Abir Alamro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 105 | |
| 2 | 2021 | 61 | |
| 3 | 2017 | 45 | |
| 4 | 2021 | 39 | |
| 5 | 2020 | 28 | |
| 6 | 2023 | 21 | |
| 7 | 2020 | 18 | |
| 8 | 2021 | 16 | |
| 9 | 2021 | 16 | |
| 10 | 2021 | 14 | |
| 11 | 2021 | 14 | |
| 12 | 2022 | 12 | |
| 13 | 2018 | 12 | |
| 14 | 2022 | 11 | |
| 15 | 2022 | 10 | |
| 16 | 2021 | 7 | |
| 17 | 2022 | 6 | |
| 18 | 2020 | 5 | |
| 19 | 2019 | 4 | |
| 20 | Frequency of occurrence of cytomegalovirus and Chlamydia pneumoniae in lymphocytes of atherosclerotic patients. | 2001 | 4 |
About Abir Alamro
Abir Alamro is a scholar working on Molecular Biology, Physiology, Pharmacology, Complementary and alternative medicine and Hematology, having authored 33 papers that have together received 468 indexed citations. Recurring topics across this work include Vitamin D Research Studies (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Long-Term Effects of COVID-19 (2 papers), Iron Metabolism and Disorders (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Graphene and Nanomaterials Applications (2 papers) and Advancements in Transdermal Drug Delivery (2 papers). The work is most often cited by research in Biological Psychiatry (28 citations), Pharmaceutical Science (45 citations), Aquatic Science (51 citations), Molecular Medicine (32 citations) and Pharmacology (42 citations). Abir Alamro has collaborated with scholars based in Saudi Arabia, Pakistan and United States. Frequent co-authors include Moudhi Almutlaq, Samina Hyder Haq, Amani Alghamdi, Tlili Barhoumi, Qura Tul Ain, Sarah Al-Rashed, Tanveer A. Wani, Seema Zargar, Majid Ahmad Ganaie and Sadia Sarwar. Their work appears in journals such as Journal of King Saud University - Science, Scientific Reports, Heliyon, Journal of Pharmacy and Pharmacology and Saudi Pharmaceutical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.